Latest Reports
Immunotherapy Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The global immunotherapy companion diagnostics market supports precision oncology by identifying patients who are most likely to benefit from immune checkpoint inhibitors and other immuno-oncology therapies. Companion diagnostics integrate ...
Tuberculosis Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The global tuberculosis (TB) diagnostics market supports the timely identification of Mycobacterium tuberculosis infection across active disease, latent infection, drug-resistant tuberculosis, and treatment monitoring. Demand is shifting fr...
Lung Cancer Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The global lung cancer companion diagnostics market supports precision oncology by identifying predictive biomarkers that determine patient eligibility for targeted therapies and immunotherapies. The market function centers on linking molec...
HIV Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The global HIV diagnostics market supports early disease identification, treatment monitoring, blood safety screening, and public health surveillance across healthcare systems. Demand is shifting from centralized laboratory testing toward d...
Hepatitis Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The global hepatitis diagnostics market supports early disease identification, treatment selection, therapeutic monitoring, and population-level screening across viral hepatitis infections. Demand is shifting toward molecular diagnostics an...
Lung Cancer Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The lung cancer diagnostics market is becoming increasingly centered on precision medicine as clinical decision-making depends on biomarker-driven patient stratification rather than histological classification alone. Diagnostic demand is ex...
Molecular Infectious Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The molecular infectious disease diagnostics market is becoming a central component of infectious disease management as healthcare systems prioritize rapid pathogen identification, antimicrobial stewardship, and decentralized diagnostic cap...
Infectious Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The infectious disease diagnostics market is becoming a critical component of global healthcare because timely pathogen identification directly influences treatment selection, antimicrobial stewardship, outbreak surveillance, and healthcare...
Clinical Sequencing Market - Strategic Insights and Forecasts (2026-2035)
Clinical sequencing is becoming an integral component of precision medicine because it enables comprehensive genomic characterization that directly informs diagnosis, prognosis, therapeutic selection, and disease monitoring. Demand is shift...
Breast Cancer Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The breast cancer diagnostics market is undergoing a structural transition as healthcare systems are placing greater emphasis on early disease detection, precision oncology, and biomarker-driven clinical decision-making. Diagnostic technolo...
Microbial Identification Market - Strategic Insights and Forecasts (2026-2031)
The global microbial identification market is expected to witness robust growth during 2021–2035, driven by the increasing prevalence of infectious diseases, rising antimicrobial resistance (AMR), growing demand for rapid diagnostic testing...
Histopathology Market - Strategic Insights and Forecasts (2026-2031)
The global histopathology market continues to expand as healthcare systems prioritise accurate tissue-based diagnosis for cancer and other chronic diseases. Rising biopsy volumes, increasing oncology screening programs, and the growing adop...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.